Drug discovery is a critical issue in the pharmaceutical research as it is a very cost effective and time consuming process to produce new drug candidate. So, there is number of computational advances which have significant impact in the field of computer aided drug design over the last several years. These advances can be grouped into three basic areas: conformational modeling (of small molecules, macromolecules and their complexes), property modeling (of physical, biological and chemical properties) and molecular design (to optimize physical, biological or chemical properties). Hence, computational approaches have given a tremendous opportunity to pharmaceutical companies to identify new potential drug targets which in turn affect the success and time of performing clinical trials for discovering new drug targets.
Introduction
The drug discovery and designing is a very complex and expensive process due to the high costs of R&D and human clinical trials. In 2001 Pharmaceutical research and manufacturers of America (PhRMA) estimated the cost of total drug discovery process about $880 million over a period of 14 years from the initial research stage to the successful marketing of a new drug. 1 So, it requires an interdisciplinary approach to design effective and potential drugs. Thus, Computer aided drug design (CADD) exploits the state-of-the-art technologies to speed up the drug development process. 2 The objective of drug design is to find a lead compound that can fit into a specific site on a target protein both geometrically and chemically. After passing the preclinical and clinical trials, this compound becomes available as drug to patients. 3 The traditional approach involves random screening of chemical compounds obtained from nature or synthesized in the laboratories. The problems associated with this method are long design cycle and high cost. But modern approach involves structure based drug design with the help computational approaches which made the drug discovery process in an efficient manner. 4, 5 So, the designing softwares with easy operation and *Corresponding Author: biswamohan81@gmail.com improved computational tools are available to generate chemically, biologically stable and nontoxic compounds. Special emphasis is given on computational approaches for drug discovery along with salient features and applications of the softwares in drug designing. 6, 7, 8 Facts about Drug Discovery Process 9, 10, 11 There are a number of factors that affect the drug discovery and development process. The important factors are given below: a. Medicinal objective: Targeting the disease state to develop potential drug candidate. b. Ability of Medicinal chemist: The attributes of the Medicinal chemist will influence the outcome of new drugs on the basis of knowledge of chemistry of lead molecule and biology of disease state. c. Screening facilities: A successful and rapid mass screening mainly depends on the capacity to evaluate a large number of compounds and detect potentially clinically useful drugs in a very short period of time. d. Drug development facility: Good facilities with interdisciplinary efforts by chemistry, biology, pharmacy and medical groups are necessary for drug development. e. Cost of new drug: The following three factors affect the cost of drug development.
Number of compounds synthesized:
Of the about 5000-10,000 compounds studied, only one drug reaches the market. Nature of the lead molecule: Cost of production will be high if the lead molecule is prepared by an expensive route.
Standards required for new drugs:
The standards required by regulatory authorities prior to release of a drug into the market have increased dramatically. In the discovery phase, each drug cost about $350 million. The Food and Drug Association processes I, II and III cost another $150 million. This brings the total to about $500 million for each drug put on to the market for consumers. 12, 13 Now days, after knowing the detail information of the target and lead molecule, a drug are designed with the help of computational tools. This can potentially save pharmaceutical companies, government and academic laboratories alike from pursuing the "wrong" leads. So, it is important to know the following ideal features of a drug molecule.
Modes of Drug Design
1. Drug must be safe and effective 2. Drug should have good bioavailability 3. Drug must be metabolically stable and with a long half-life 4. Drug should be nontoxic with minimal or no side effects 5. Drug should have selective distribution to target tissues or disease state
Computational tools used for drug design 14, 15, 16 The software that is available for drug design, discovery and development process originates from different sources. These include commercial companies, academic institutions, open source software or in-house development. These software packages also differ in terms of cost, functionality and efficacy, and automation. The salient features of generally used drug design software are given below.
Affinity
Automated, flexible docking Uses the energy of the ligand/receptor complex to automatically find the best binding modes of the ligand to the receptor (energy-driven method)
Argus lab
Argus Lab is a molecular modeling, graphics, and drug design program for Windows operating systems. Argus Lab is freely licensed. It does not need to sign anything. It consists of a user interface that displays the graphical structure of the molecules and runs quantum mechanics calculation using Argus Computing Server16. By using Argus lab we can able to build an atom, build molecules using templates, to change the structure of an atom and bond types, and to build new structures from the preexisting structures.
Auto Dock
Auto Dock is a suite of automated docking tools. It is designed to predict how small molecules, such as substrates or drug candidates, bind to a receptor of known 3D structure. Accord is user friendly and is powered by Robust and well proven chemistry engine that can be used for any type of chemistry. This software is used for carrying out sequence analysis, gene expression, prediction of ADME properties and check the toxicity profile of the drugs.
f. CHARMM CHARMM (Chemistry at Harvard Macromolecular Mechanics) is the name of a widely used set of force fields for molecular dynamics as well as the name for the molecular dynamics simulation and analysis package associated with them. The CHARMM force fields for proteins include: united-atom (sometimes called "extended atom") CHARMM19, all-atom CHARMM22 and its dihedral potential corrected variant CHARMM22/CMAP. CHARMM also includes polarizable force fields using two approaches. One is based on the fluctuating charge (FQ) model, also known as Charge Equilibration (CHEQ). The other is based on the Drude shell or dispersion oscillator model.
g. MODELLER
MODELLER is a computer program used in producing homology models of protein tertiary structures as well as quaternary structures. It implements a technique inspired by nuclear magnetic resonance known as satisfaction of spatial restraints, by which a set of geometrical criteria are used to create a probability density function for the location of each atom in the protein. The method relies on an input sequence alignment between the target amino acid sequence to be modeled and a template protein whose structure has been solved. MODELLER was originally written and is currently maintained by Andrej Sali at the University of California, San Francisco.
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h. TOPKAT
It is a computer-assisted toxicology prediction program which is available from Accelrys.
i. Tsar
It is a a fully integrated analysis package for investigation of Quantitative Structure-Activity Relationships (QSARs).
j. Ludi
It fits molecules into the active site of a receptor by matching complementary polar and hydrophobic groups. It suggests modifications to increase the binding affinity of ligand.
Schrodinger
Schrodinger software is drug design software using both ligand and structure-based methods. It provides accurate, reliable, and high performance computational technology to solve real world problems in life science research. It provides superior solutions and services for the design, selection, and optimization of novel drug candidates. Schrödinger's predictive models will enable drug discovery scientists to assess properties of chemical compounds early in the discovery process and to select drug candidates that have optimal profiles. The predictive power of Schrödinger's software allows scientists to accelerate their research and development activities, reduce research costs, and make novel discoveries that might not be possible with other computational or experimental approaches. 19, 20 The various products of Schrodinger are: 
b. Prime
Prime is a fully-integrated protein structure prediction program. Prime is a powerful and complete tool for generating accurate receptor models for structure-based drug design. Homology modeling and fold recognition can be done using prime. Prime allows the users to specify and adjust parameters to optimize the quality of predictions. c. Jaguar Jaguarn is quantum mechanics software for small molecules. It is a high performance ab-intio package for both gas and solution phase recreation, with particular strength in treating metal containing systems. Jaguar proceeds faster than the other conventional methods and it makes more possible to carry out more calculations at a single time. Jaguar computes a comprehensive array of molecular properties such as NMR, IR, pKa, partial charges, electron density, electrostatic potential and NBO analysis. It also generates potential energy surface with respect to differences in the internal coordinates.
d. Macro Model
Macro Model is a complete molecular mechanics based modeling (minimization, conformational analysis) of bioorganic systems using a variety of force fields which provides accurate results. Force field molecular modeling is used to examine molecular conformations, molecular motions and inter molecular interactions such as ligand receptor complex. It can also perform molecular dynamics at constant temperatures using mixed Monte Carlo algorithm and stochastic dynamics. They help wide range of searching methods and handling systems in the range of small molecules to entire proteins. Different types of force fields such as MM2, MM3, AMBER, AMBER 94, MMFF, and OPLS-AA are supported by Macro Model to do a wide range of research applications.
e. Liaison
It predicts ligand binding free energies using the linear interaction approximation.
f. QSite
It couples Jaguar's QM capabilities with classical molecular mechanics allowing efficient description of chemical reactions in enzyme active sites. The hybrid QM/MM model can also be used for the prediction of binding afinities in cases where classical force fields are unreliable (e.g. significant anisotropic polarization).
g. Maestro
Maestro is the unified interface for all Schrödinger software. Impressive rendering capabilities, a powerful selection of analysis tools, and an easy-touse design combine to make Maestro a versatile modelling environment for all researchers. Schrodinger is proud to make Maestro available to academic users at no charge. Maestro is a powerful and versatile molecular modeling environment, and the portal to the most advanced science in computational chemistry.
h. LigPrep
It generates and cleans up 3D models of bioorganic molecules. This tool is also able to generate 3D structures of possible tautomers and stereoisomers based on 2D representation of the molecule.
i. Phase
It facilitates ligand-based drug design by identifying a pharmacophore based on structures of active compounds
j. Strike
It facilitates ligand-based drug design via quantitative analysis of structure-activity relationships.
k. Induced Fit
It combines the capabilities of Prime and Glide to take into account possible changes in the protein structure upon ligand binding.
l. SiteMap
It identifies possible binding sites, setting up the target protein for subsequent docking studies.
m. Desmond
It is highly parallel molecular dynamics simulation program for macromolecules
n. Impact
It is a molecular mechanics program specifically designed to handle large macromolecular simulations. The program effortlessly treats simulations on ligand-protein systems in solvation or in vacuo enabling the study of large systems in a timely manner. SYBYL SYBYL is a general molecular modelling program written by Tripos. The SYBYL suite of computational informatics software is designed to enhance the drug discovery workflows and decisionmaking of today's computational chemists and molecular modelers. SYBYL provides the fundamental components for understanding molecular structure and properties with an emphasis on the discovery of lead candidates. SYBYL applications include validated solutions for key computational chemistry and molecular modelling tasks such as ligand-based design, receptor-based design, structural biology, library design, and cheminformatics. SYBYL, the heart of Tripos expert molecular modeling environment, provides the fundamental components for understanding molecular structure and properties with a special focus on the creation of new chemical entities. descriptors for use with statistical methods in order to create QSAR and QSPR models that predict biological activity or physical properties of new molecules. 4. ClogP/CMR: The ClogP/CMR6 application provides highly accurate calculated logP and molar refractivity values. 5. VolSurf: VolSurf predicts ADME properties using pre-calculated models; computes unique, ADME-relevant descriptors; and creates QSAR models of bioactivity or property. 6. HQSAR: Hologram QSAR (HQSAR) uses molecular holograms and PLS to generate fragment based structure-activity relationships. 7. GALAHAD: GALAHAD7 allows researchers to automatically develop pharmacophore hypotheses and structural alignments from a set of molecules that bind at a common site.
8. GASP: GASP8 performs pharmacophore elucidation without requiring prior knowledge of pharmacophore elements or constraints. 9. Tuplets: Tuplets facilitates the retrieval of compounds from molecular structure databases that are likely to exhibit biological activity. Additionally, Tuplets can be used to prioritize virtual combinatorial libraries for pharmaceutical research and can provide a biasing descriptor to allow the design of focused combinatorial libraries.
DISCOtech:
DISCOtech10 performs pharmacophore elucidation from a set of active compounds. Starting from a set of representative conformers for each molecule, DISCOtech considers all possible mappings of features to create a set of alignments, each of which is a hypothesis for the pharmacophore and its geometry. 11. Surflex-Dock: Surflex-Dock9 offers unparalleled enrichments in virtual high-throughput screening combined with state-of-the-art speed, accuracy, and usability. 12. CScore: CScore uses multiple types of scoring functions to rank the affinity of ligands bound to the active site of a receptor. This software suite has been developed in such a way that it can be used for genome analysing, sequence analysing, 3D modelling, simulation, manipulation, structural changes, drug design, pathway modelling, SNP analysis and comparative genomics. The suite runs on platforms such as Compaq, IBM Aix, SGI, Linux clusters and the operating systems of Unix and Linux flavours, the official said. The 3D structure manipulations in the module will help in building molecules, side chain placements and stereo chemical editing and the drug design model will help in developing de-novo designs with high throughput screening of chemical databases, the official claimed. 23 
Conclusion
Drug designing softwares has potential role to design novel proteins or drugs in biotechnology or pharmaceutical field. The drug designing softwares are used to analyze molecular modeling of gene, gene expression, gene sequence analysis and 3D structure of proteins. In addition, drug designing area has important role in the diagnosis of diseases such as lung cancer, brain cancer, breast cancer and Alzheimer disease. This review article summarizes the structure based drug designing and ligand based drug designing softwares and their applications in the field of medicinal research. 
